Table 3 Outcomes according to the presence of diaphragm dysfunction at ECMO Day 1
|  | All patients (n = 63) | Diaphragm dysfunction (n = 39) | No diaphragm dysfunction (n = 24) | P value |
|---|---|---|---|---|
Tracheostomy, n (%) | 25 (43) | 15 (41) | 10 (48) | 0.600 |
Number of VAP episodes | 3 (2–4) | 3 (2–5) | 3 (2–4) | 0.397 |
Total MV duration, days | 50 (37–71) | 50 (34–70) | 49 (38–73) | 0.845 |
In survivors (n = 24), days | 60 (38–85) | 67 (47–82) | 42 (35–85) | 0.590 |
MV post-ECMO, days | 20 (12–29) | 27 (14–31) | 14.5 (10.3–23) | 0.157 |
In survivors (n = 24), days | 18 (12–29) | 27 (14–31) | 14 (9.5–21) | 0.124 |
ECMO duration, days | 38 (18–56) | 36 (26–53) | 41 (18–57) | 0.705 |
In survivors (n = 24), days | 32 (17–47) | 36 (18–45) | 27 (14–51) | 0.543 |
ICU length of stay, days | 47 (1–83) | 61 (11–97) | 38 (1–54) | 0.298 |
In survivors, days | 65 (46–101) | 86 (61–113) | 47 (40–89) | 0.134 |
ICU Mortality, n (%) | 39 (62) | 26 (67) | 13 (54) | 0.321 |